Laure-Anne Teuwen
@lateuwen
MD, PhD from Belgium 🇧🇪 🌍 Medical Oncologist @UZAnieuws Postdoc researcher @Stkstichting @MSF @OncologyBGLab Guest professor @UAntwerpen #globaloncology
You might like
We did a thing! We have now created Monthly Newsletters!! Subscribe to our website for monthly updates on exciting things happening at @OncologyBGLab ! oncologybg.com/2025/11/03/mon… @brianshkabarii
Don’t forget to read our @OncologyBGLab article by @SamuelXStevens @lateuwen and @oncology_bg on November issue of @TheLancetOncol. thelancet.com/journals/lanon…
🚨Our Nov issue is live - thelancet.com/issue/S1470-20… 📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma 📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)
ESMO Round up @ecancer video from @oncology_bg is now out! Watch for an unbiased commentary on the most important trials and studies from #ESMO25. This 35 minute video will give you the best of ESMO plus critical appraisal and minus the hype. ecancer.org/en/video/12543…
First @TheLancetOncol paper is a special moment indeed. We’re lucky to have an outstanding mentor like you - true mentorship like this is rare.
But the most important of all- This paper was led by 2 stellar, smart, brilliant mentees- our @csoncol fellow @SamuelXStevens and my visiting fellow @lateuwen from Antwerp, Belgium who spent 6 weeks with us in August and September. That’s exactly when the new FDA guidance came…
We just published in @TheLancetOncol a very important paper regarding the new FDA guidance on overall survival assessment in cancer drug trials. Right in time for #ESMO25. Please do read. I promise you that you’ll learn something that’s applicable broadly. And follow along this…
🆕Online: Overall survival assessment in cancer drug trials: a luxury or a necessity? @SamuelXStevens, @lateuwen, and @oncology_bg discuss the #FDA draft guidance on overall survival in randomised cancer drug trials thelancet.com/journals/lanon…
Very proud to have co-authored this comment on the FDA’s new draft guidance for industry in @TheLancetOncol with @lateuwen and @oncology_bg. The draft guidance takes important steps forward, but there is room for even more improvement. Read more: thelancet.com/journals/lanon…
Sharing #myESMOStory after our @myESMO Leadership Program meeting🚀 ESMO gave me the opportunity to join this incredible program together with oncologists from different countries in the 🌎, all sharing the same goal of improving cancer care at all levels! #gratitude @OncoAlert
What an amazing feat the @BalcoMedical team pulled off .. meeting attended by >1000 with almost 200 from india, 12 globally from australia, NZ, UK, USA, Lebanon, Switzerland, singapore. key tracks were mini Accord research workshop, communication skills with role play to train…
Save the Date! Join us for the #BreastCancer Debate of the Year and the most exciting highlights of 2025. Stay tuned - full program details coming soon! January 16-17, 2026 at The Hotel, Brussels. @JulesBordet @mybsmo, Hans Wildiers
It is a honor to serve as editor @JCOGO_ASCO @ASCO 👩🏻⚕️👨🏻🎓🌍🦀 Thanks for your leadership @KVanLoonMD and all the ones that have supported this wonderful journal @GlopesMd @VanderpuyeVerna @profevasegelov @lateuwen
Thank you to the many, many 🌟peer reviewers who support @JCOGO_ASCO in publishing high quality global cancer research and knowledge! 🙏🏻@BourlonMaite @VanderpuyeVerna @fabiomoraesmd @nadahamad @SastriSupriya
Thrilled and honored to be selected for the #ESMOLGP 2025–26! Grateful to @myESMO faculty for this opportunity and excited to start this journey with fellow oncologists worldwide.
Honored to have been accepted into the @myESMO Leadership Programme 2025–2026 Grateful for the opportunity to learn and grow alongside colleagues from around the world esmo.org/career-develop… @DFCI_BreastOnc
We @OncologyBGLab had a very productive August. Please tag along for an update on the major accomplishments from our team in August. 1. Our visiting colleague @lateuwen published an editorial in @JNCI_Now about clinical versus statistical significance. academic.oup.com/jnci/advance-a…
Super proud of @lateuwen who is here with us @OncologyBGLab @QueensuSCRI for a month long fellowship and did a fantastic grand rounds talk today. Her recalling of how we initially met at #asco22 was nostalgic and made me even prouder of what she has achieved since. During this…
It was very inspiring to see our own @lateuwen present one of the most inspiring grand rounds on global oncology today @queensoncology @QueensUHealth. She embodies the example of doing global oncology the right way.
Our new editorial just published in @BMJOncology led by @lateuwen where we discuss the use of inferior control arm in cancer drug trials run in LMICs. bmjoncology.bmj.com/content/4/1/e0…
Congratulations to @lateuwen who got 2 papers published in her 1 month sabbatical with us @OncologyBGLab ! Both are open access- 1. bmjoncology.bmj.com/content/4/1/e0… @BMJOncology 2. academic.oup.com/jnci/advance-a… @JNCI_Now
Being in Kigali and engaging with the fellows was an absolute privilege. Their drive and commitment are inspiring - and a clear reflection of your leadership @Rubagumyaf. Thank you for the opportunity to contribute to this important #GlobalOncology effort.
A year ago, I shared the launch of the medical oncology fellowship @Uni_Rwanda. Since then, global colleagues have stepped up—teaching remotely and even visiting Kigali, like @lateuwen, for in-person sessions. Grateful for this #GlobalOncology solidarity.
Hello everyone 👋 @darioT_ @rillepihlak and I are working on a Lancet Oncology commission on how cancer care can be more patient focused. Our work is studying the psychosocial aspects of #MedEd. We'd be so 🙏 if you could help with this short survey! docs.google.com/forms/d/e/1FAI…
United States Trends
- 1. Cowboys 40.3K posts
- 2. Eagles 64.6K posts
- 3. Nimmo 13.6K posts
- 4. George Pickens 4,842 posts
- 5. Browns 57K posts
- 6. Trevor Lawrence 2,993 posts
- 7. Mets 19.8K posts
- 8. Myles Garrett 6,457 posts
- 9. Ceedee 7,747 posts
- 10. Semien 8,877 posts
- 11. Raiders 41.2K posts
- 12. Shedeur 57.5K posts
- 13. Colts 40.5K posts
- 14. Giants 88.1K posts
- 15. Chiefs 83.4K posts
- 16. Turpin 3,231 posts
- 17. Geno 9,633 posts
- 18. Gibbs 18.7K posts
- 19. Jerry Jeudy 4,972 posts
- 20. Jags 4,293 posts
Something went wrong.
Something went wrong.